Difference between revisions of "Template:Antithrombotics"

From blackwiki
Jump to navigation Jump to search
blackwiki>Jeetmahal
(betrixaban is in Phase 3 trials currently)
m (131 revisions imported)
 
(11 intermediate revisions by 8 users not shown)
Line 12: Line 12:
 
* [[Abciximab]]
 
* [[Abciximab]]
 
* [[Eptifibatide]]
 
* [[Eptifibatide]]
 +
* [[Orbofiban]]
 +
* [[Roxifiban]]
 +
* [[Sibrafiban]]<sup>§</sup>
 
* [[Tirofiban]]
 
* [[Tirofiban]]
* [[Roxifiban]]
 
* [[Orbofiban]]
 
  
 
   | group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
 
   | group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
Line 45: Line 46:
 
   | list5 =
 
   | list5 =
 
* [[Thromboxane synthase inhibitors]]
 
* [[Thromboxane synthase inhibitors]]
** [[Dipyridamole]] ([[Acetylsalicylic acid/dipyridamole|+Aspirin]])
+
** [[Dipyridamole]] ([[Acetylsalicylic acid/dipyridamole|+ aspirin]])
 
** [[Picotamide]]
 
** [[Picotamide]]
 +
** [[Terbogrel]]
 
* [[Thromboxane receptor antagonist|Receptor antagonist]]s
 
* [[Thromboxane receptor antagonist|Receptor antagonist]]s
** [[Terutroban]]<sup></sup>
+
** [[Terbogrel]]
 +
** [[Terutroban]]<sup>§</sup>
  
 
   | group6 = [[Phosphodiesterase inhibitor]]s
 
   | group6 = [[Phosphodiesterase inhibitor]]s
Line 86: Line 89:
 
     | group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
 
     | group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
 
     | list1 =
 
     | list1 =
* [[Low molecular weight heparin]]
+
* [[Low-molecular-weight heparin]]
 
** [[Bemiparin sodium|Bemiparin]]
 
** [[Bemiparin sodium|Bemiparin]]
 
** [[Certoparin sodium|Certoparin]]
 
** [[Certoparin sodium|Certoparin]]
Line 94: Line 97:
 
** [[Parnaparin sodium|Parnaparin]]
 
** [[Parnaparin sodium|Parnaparin]]
 
** [[Reviparin sodium|Reviparin]]
 
** [[Reviparin sodium|Reviparin]]
** [[Tinzaparin sodium|Tinzaparin]]<sup>‡</sup>
+
** [[Tinzaparin sodium|Tinzaparin]]
 
* [[Oligosaccharide]]s
 
* [[Oligosaccharide]]s
 
** [[Fondaparinux]]
 
** [[Fondaparinux]]
Line 103: Line 106:
 
** [[Sulodexide]]
 
** [[Sulodexide]]
  
     | group2 = [[Direct Xa inhibitor]]s
+
     | group2 = [[Direct Xa inhibitor]]s ("xabans")
 
     | list2 =
 
     | list2 =
* Xabans
+
* [[Apixaban]]
** [[Apixaban]]
+
* [[Betrixaban]]
** [[Betrixaban]]<sup>†</sup>
+
* [[Darexaban]]<sup>§</sup>
** [[Darexaban]]<sup>§</sup>
+
* [[Edoxaban]]
** [[Edoxaban]]
+
* [[Otamixaban]]<sup>§</sup>
** [[Otamixaban]]<sup>§</sup>
+
* [[Rivaroxaban]]
** [[Rivaroxaban]]
 
  
 
   }}
 
   }}
Line 125: Line 127:
 
* [[Direct thrombin inhibitor#Univalent|Univalent]]: [[Argatroban]]
 
* [[Direct thrombin inhibitor#Univalent|Univalent]]: [[Argatroban]]
 
* [[Dabigatran]]
 
* [[Dabigatran]]
 +
* [[Efegatran]]
 +
* [[Inogatran]]<sup>§</sup>
 
* [[Melagatran]]<sup>‡</sup>
 
* [[Melagatran]]<sup>‡</sup>
 
* [[Ximelagatran]]<sup>‡</sup>
 
* [[Ximelagatran]]<sup>‡</sup>
Line 142: Line 146:
 
  | list3 =
 
  | list3 =
 
* [[Plasminogen activator]]s: [[Recombinant tissue plasminogen activators|r-tPA]]
 
* [[Plasminogen activator]]s: [[Recombinant tissue plasminogen activators|r-tPA]]
** [[Tissue plasminogen activator|Alteplase]]
+
** [[Alteplase]]
 
** [[Reteplase]]
 
** [[Reteplase]]
 
** [[Tenecteplase]]
 
** [[Tenecteplase]]
 +
** [[Desmoteplase]]<sup>†</sup>
 
* UPA
 
* UPA
 
** [[Saruplase]]
 
** [[Saruplase]]
Line 155: Line 160:
 
* [[Fibrinolysin]]
 
* [[Fibrinolysin]]
  
  | group4 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
+
  | group4 = [[Anticoagulant|Non-medicinal]]
 
  | list4 =
 
  | list4 =
 
* [[Citrate]]
 
* [[Citrate]]
Line 162: Line 167:
  
 
  | belowstyle = background: transparent; padding: 0px;
 
  | belowstyle = background: transparent; padding: 0px;
  | below = {{PharmNavFootnote}} {{Myeloid navs}}
+
  | below = {{PharmNavFootnote}}  
  
 
}}<noinclude>
 
}}<noinclude>

Latest revision as of 14:27, 22 October 2020

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Antithrombotics|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Antithrombotics|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Antithrombotics|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.